Further mechanistic studies have shown that DIPAH3 inhibition promotes the antioxidant effect mediated by TrxR1 and GPX4, the key factors of selenium metabolism, increases the levels of peroxides and ROS, and ultimately inhibits the malignant phenotype of pancreatic cancer [52]. This evidence concerns the gene GPX4 and familial pancreatic carcinoma.